Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Davi

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Obstetrics and Gynecology|October 1, 1977
Maternal plasma estrogens after dehydroepiandrosterone-sulfate injection into the fetusO Gamissans, G R Wilson, J Cuyas, et al.
Obstetrics and Gynecology|December 1, 1976
Treatment of fibrocystic disease of the breast with a prolactin inhibitor: 2-Br-alpha-ergocryptine (CB-154)J Martin-Comin, P Pujol-Amat, V Cararach, et al.
International Urogynecology Journal and Pelvic Floor Dysfunction|October 2, 2002
Pubic bone anchoring devices for the surgical treatment of urinary stress incontinence in patients with severe genital prolapseX Iglesias, M Espuña, M Puig, et al.
Cancer|May 15, 1990
Endolymphatic chemotherapy in gynecologic cancerA Tarrats, X Cot, J M Lailla, et al.
Revista De Neurologia|December 19, 2018
[Anti-NMDA receptor encephalitis. Early diagnosis and treatment in patients with acute-subacute psychotic symptoms]N Guanyabens-Busca, V Casado-Ruiz, E Gine-Serven, et al.
European Journal of Gynaecological Oncology|January 1, 1988
Intraarterial infusion chemotherapy as a primary treatment in cancer of uterine cervix limited to the pelvisJ A Lejarcegui, X Cot, J M Lailla, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Obstetrics and Gynecology|October 1, 1977
Maternal plasma estrogens after dehydroepiandrosterone-sulfate injection into the fetusO Gamissans, G R Wilson, J Cuyas, et al.
Obstetrics and Gynecology|December 1, 1976
Treatment of fibrocystic disease of the breast with a prolactin inhibitor: 2-Br-alpha-ergocryptine (CB-154)J Martin-Comin, P Pujol-Amat, V Cararach, et al.
International Urogynecology Journal and Pelvic Floor Dysfunction|October 2, 2002
Pubic bone anchoring devices for the surgical treatment of urinary stress incontinence in patients with severe genital prolapseX Iglesias, M Espuña, M Puig, et al.
Cancer|May 15, 1990
Endolymphatic chemotherapy in gynecologic cancerA Tarrats, X Cot, J M Lailla, et al.
Revista De Neurologia|December 19, 2018
[Anti-NMDA receptor encephalitis. Early diagnosis and treatment in patients with acute-subacute psychotic symptoms]N Guanyabens-Busca, V Casado-Ruiz, E Gine-Serven, et al.
European Journal of Gynaecological Oncology|January 1, 1988
Intraarterial infusion chemotherapy as a primary treatment in cancer of uterine cervix limited to the pelvisJ A Lejarcegui, X Cot, J M Lailla, et al.
Pageof 1